1. Tam SHY, Hirsch JD, Watanabe JH. Medication Regimen Complexity in Long-Term Care Facilities and Adverse Drug Events-Related Hospitalizations. The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 2017;32(5):281-84. doi: 10.4140/TCP.n.2017.281 [published Online First: 2017/05/10]

2. Dwyer LL, Han B, Woodwell DA, et al. Polypharmacy in nursing home residents in the United States: results of the 2004 National Nursing Home Survey. The American journal of geriatric pharmacotherapy 2010;8(1):63-72. doi: 10.1016/j.amjopharm.2010.01.001 [published Online First: 2010/03/17]

3. Gallagher P, Lang PO, Cherubini A, et al. Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals. European journal of clinical pharmacology 2011;67(11):1175-88. doi: 10.1007/s00228-011-1061-0 [published Online First: 2011/05/18]

4. Hamilton HJ, Gallagher PF, O'Mahony D. Inappropriate prescribing and adverse drug events in older people. BMC geriatrics 2009;9:5. doi: 10.1186/1471-2318-9-5 [published Online First: 2009/01/30]

5. O'Connor MN, Gallagher P, O'Mahony D. Inappropriate prescribing: criteria, detection and prevention. Drugs & aging 2012;29(6):437-52. doi: 10.2165/11632610-000000000-00000 [published Online First: 2012/05/31]

6. Woolcott JC, Richardson KJ, Wiens MO, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Archives of internal medicine 2009;169(21):1952-60. doi: 10.1001/archinternmed.2009.357 [published Online First: 2009/11/26]

7. Weich S, Pearce HL, Croft P, et al. Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study. BMJ (Clinical research ed) 2014;348:g1996. doi: 10.1136/bmj.g1996 [published Online First: 2014/03/22]

8. Wu C, Bell CM, Wodchis WP. Incidence and economic burden of adverse drug reactions among elderly patients in Ontario emergency departments: a retrospective study. Drug safety 2012;35(9):769-81. doi: 10.2165/11599540-000000000-00000 [published Online First: 2012/07/25]

9. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. Journal of the American Geriatrics Society 2015;63(11):2227-46. doi: 10.1111/jgs.13702 [published Online First: 2015/10/09]

10. O'Mahony D, O'Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age and ageing 2015;44(2):213-8. doi: 10.1093/ageing/afu145 [published Online First: 2014/10/18]

11. Levinson W. Choosing Wisely Canada [Available from: www.choosingwiselycanada.org/ accessed September 3rd, 2017.

12. McDonald EG, Wu PE, Rashidi B, et al. The MedSafer Study: a controlled trial of an electronic decision support tool for deprescribing in acute care. J Am Geriatr Soc. 2019;67:1843-1850.

13. Tannenbaum C. EMPOWER brochures [Available from: www.deprescribing.org/resources/deprescribing-information-pamphlets/ accessed October 15 2017.

14. Martin P, Tannenbaum C. Use of the EMPOWER brochure to deprescribe sedative-hypnotic drugs in older adults with mild cognitive impairment. BMC geriatrics 2017;17(1):37. doi: 10.1186/s12877-017-0432-5 [published Online First: 2017/02/02]

15. Tannenbaum C, Martin P, Tamblyn R, et al. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA internal medicine 2014;174(6):890-8. doi: 10.1001/jamainternmed.2014.949 [published Online First: 2014/04/16]

16. Tannenbaum C, Farrell B, Shaw J, et al. An Ecological Approach to Reducing Potentially Inappropriate Medication Use: Canadian Deprescribing Network. Canadian journal on aging = La revue canadienne du vieillissement 2017;36(1):97-107. doi: 10.1017/s0714980816000702 [published Online First: 2017/01/17]

17. Reeve, E, Low, LF, Shakib, S, & Hilmer, S N. Development and Validation of the Revised Patients’ Attitudes Towards Deprescribing (rPATD) Questionnaire: Versions for Older Adults and Caregivers. Drugs & Aging 2016;33(12), 913-928.